22.39
6.79%
-1.63
After Hours:
23.03
0.64
+2.86%
GeneDx Holdings Corp stock is currently priced at $22.39, with a 24-hour trading volume of 345.67K.
It has seen a -6.79% decreased in the last 24 hours and a +143.37% rose in the past month.
The chart indicates a potential bearish trend, as the stock is below the $23.28 pivot point. If it approaches the $22.24 support level, significant changes may occur.
Previous Close:
$24.02
Open:
$23.85
24h Volume:
345.67K
Market Cap:
$585.52M
Revenue:
$202.57M
Net Income/Loss:
$-175.77M
P/E Ratio:
-0.6296
EPS:
-35.5597
Net Cash Flow:
$-185.86M
1W Performance:
+7.90%
1M Performance:
+143.37%
6M Performance:
+1,299%
1Y Performance:
+262.00%
GeneDx Holdings Corp Stock (WGS) Company Profile
Name
GeneDx Holdings Corp
Sector
Industry
Phone
800 298 6470
Address
North Tower, 8th Floor 333 Ludlow Street, Stamford
GeneDx Holdings Corp Stock (WGS) Latest News
Insider Buying: GeneDx Holdings Corp. (NASDAQ:WGS) Director Acquires 50000 Shares of Stock - Defense World
Defense World
GeneDx (NASDAQ:WGS) Shares Gap Up on Insider Buying Activity - Defense World
Defense World
GeneDx Holdings Corp [NASDAQ: WGS] Sees Decrease in Stock Value – Knox Daily - Knox Daily
Knox Daily
Casdin Capital buys $1.17 million in GeneDx Holdings shares - Investing.com
Investing.com
GeneDx Holdings Corp (WGS) can make a big difference with a little luck – Sete News - SETE News
SETE News
Casdin Capital, Llc Acquires 50,000 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) Stock - MarketBeat
MarketBeat
GeneDx Holdings Corp Stock (WGS) Financials Data
GeneDx Holdings Corp (WGS) Revenue 2024
WGS reported a revenue (TTM) of $202.57 million for the quarter ending December 31, 2023, a -13.69% decline year-over-year.
GeneDx Holdings Corp (WGS) Net Income 2024
WGS net income (TTM) was -$175.77 million for the quarter ending December 31, 2023, a +67.98% increase year-over-year.
GeneDx Holdings Corp (WGS) Cash Flow 2024
WGS recorded a free cash flow (TTM) of -$185.86 million for the quarter ending December 31, 2023, a +44.27% increase year-over-year.
GeneDx Holdings Corp (WGS) Earnings per Share 2024
WGS earnings per share (TTM) was -$7.4397 for the quarter ending December 31, 2023, a +86.34% growth year-over-year.
About GeneDx Holdings Corp
Sema4 Holdings Corp., doing business as Sema4, operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data. The company provides Centrellis, an AI-driven health intelligence platform that delivers comprehensive insights to biopharma to accelerate the drug discovery, development, and commercialization life-cycle, as well as analytics for actionable insights, pre-clinical and clinical trial support, and advanced sequencing services. It also offers Sema4 Signal that enables and advances precision oncology care, from prevention to treatment to remission; and testing for carrier screening, noninvasive prenatal testing, and newborn screening, as well as hereditary cancer testing. In addition, the company provides COVID-19 testing solutions. Sema4 Holdings Corp. was incorporated in 2020 and is headquartered in Stamford, Connecticut.
Cap:
|
Volume (24h):